References

1. Laport GF, Larson RA: Treatment of adult acute lymphoblastic leukemia. Semin Oncol 24:70-82, 1997.

2. Schiffer CA: Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both? J Clin Oncol 21:760-761, 2003.

3. Hoelzer D, Gokbuget N, Digel W, et al.: Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 99:4379-4385, 2002.

4. Hoelzer D, Gokbuget N: New approaches to acute lym-phoblastic leukemia in adults: where do we go? Semin Oncol 27:540-559, 2000.

5. Deininger M, Buchdunger E, Druker BJ: The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105:2640-2653, 2005.

6. Cortes J, Giles F, O'Brien S, et al.: Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha. Blood 102:83-86, 2003.

7. Radich J, Gathmann I, Kaeda J, et al.: Molecular responses to imatinib and interferon+ ara-C in newly diagnosed CML. Blood 102(II):Abstract 635, 2003.

0 0

Post a comment